Human cytokines suppress apoptosis of leukaemic CD5+ B cells and preserve expression of bcl-2

Immunology and Cell Biology

Volumn 75, Issue 2, 1997, Pages 127-135

  Tangye, Stuart G ^a,b   Raison, Robert L ^a  

^a UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

apoptosis; bcl 2; CD5+ B cells; CLL; cytokines

Indexed keywords

CD5 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; B CELL LEUKEMIA; B LYMPHOCYTE; CANCER CELL CULTURE; CELL DEATH; CELL POPULATION; CELL STIMULATION; CELL SURVIVAL; CELL VIABILITY; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DNA SYNTHESIS; HUMAN; HUMAN CELL; LEUKEMIA CELL; PROTEIN EXPRESSION;

EID: 0030894009     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1038/icb.1997.17     Document Type: Article

References (39)

1. Dighiero G, Travade P, Chevret S, Fenaux P, Chastang C, Binet JL, and the French Cooperative Group on CLL, B-cell chronic lymphocytic leukemia: Present status and future directions. Blood 1991; 78: 1901-14.
2. Andreeff M, Darzynkiewicz Z, Sharpless T, Clarkson BD, Melamed MR. Discrimination of human leukemia subtypes by blow cytometric analysis of cellular DNA and RNA. Blood 1980; 55: 282-93.
3. Hoffbrand AV, Panayiotidis P, Reittie J, Ganeshaguru K. Autocrine and paracrine growth loops in chronic lymphocytic leukemia. Semin. Hematol. 1993; 30: 306-17.
4. Schena M, Larsson LG, Gottardi D et al. Growth- and differentiation-associated expresion of bcl-2 in B-chronic lymphocytic leukemia cells. Blood 1992; 79: 2981-9.
5. Lantz O, Grillot-Courvalin C, Schmitt C, Fermand JP, Brouet JC. Interleukin-2-induced proliferation of leukaemic human B cells. J. Exp. Med. 1985; 161: 1225-30.
6. Fluckiger AC, Rossi JF, Bussel A, Bryon P, Banchercau J, Defrance I. Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors. Blood 1992; 80: 3173-81.
7. Fluckiger AC, Garrone P, Durand I, Galizzi JP, Banchereau J. Interleukin 10 (IL-10) upregulates functional high affinity IL-2 receptors on normal and leukaemic B lymphocytes. J. Exp. Med. 1993; 178: 1473-81.
8. Fluckiger AC, Briere F, Zurawski G, Bridon JM, Banchereau J. IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukemia cells. Immunology 1994; 83: 397-403.
9. van Kooten C, Rensink I, Aarden L, van Oers R. Cytokines and intracellular signals involved in the regulation of B-CLL proliferation. Leuk. Lymphoma 1994; 12: 27-33.
10. Ostlund L, Einhorn S, Robert KH, Juliusson G, Biberfeld P. Chronic B-lymphocytic leukemia cells proliferate and differentiate following exposure to interferon in vitro. Blood 1986; 67: 152-9.
11. Uggla C, Aguilar-Santelises M, Rosen A, Mellstedt H, Jondal M. Spontaneous production of interleukin 1 activity by chronic lymphocytic leukaemia cells. Blood 1987; 70: 1851-7.
12. Biondi A, Rossi V, Bassan R et al. Constitutive expression of the interleukin-6 gene in chronic lymphocytic leukemia. Blood 1984; 73: 1279-84.
13. Foa R, Massaia M, Cardona S et al. Production of tumor necrosis factor-α by B cell chronic lymphocytic leukemia cells: A possible regulatory role of TNF in the progression of the disease. Blood 1990; 76: 393-400.
14. Schena M, Gaidano G, Gottardi D et al. Molecular investigation of the cytokines produced by normal and malignant B lymphocytes. Leukemia 1992; 6: 120-5.
15. Adami F, Guarini A, Pini M et al. Serum levels of tumor necrosis factor-α in patients with B-cell chronic lymphocytic leukemia. Eur. J. Cancer 1994; 30A: 1259-63.
16. Buschle M, Campana D, Carding SR, Richard C, Brenner MK, Hoffbrand AV. Interferon-γ inhibits apoptotic cell death in B cell chronic lymphocytic leukemia. J. Exp. Med. 1993; 177: 213-18.
17. Sarfati M. Interleukin-4 and the two isoforms of CD23 antigen: Their possible contribution to the physiopathology of chronic lymphocytic leukemia. Nouv. Rev. Fr. Hematol. 1993; 35: 109-13.
18. Collins RJ, Verschuer LA, Harmon BV, Prentice RL, Pope JH, Kerr JFR. Spontaneous programmed death (apoptosis) of B-chronic lymphocytic leukemia cells following their culture in vitro. Br. J. Haem. 1989; 71: 343-50.
19. + B cell apoptosis. Coincidence of cell death and DNA fragmentation with reduced bcl-2 expression. Br. J. Haematol. 1996; 92: 950-3.
20. Dancescu M, Rubio-Trujillo M, Biron G et al. Interleukin-4 protects chronic lymphocytic leukemia cells from death by apoptosis and upregulates bcl-2 expression. J. Exp. Med. 1992; 176: 1319-26.
21. Panayiotidis P, Ganeshaguru K, Jabbar SA, Hoffbrand AV. Interleukin-4 inhibits apoptotic cell death and loss of the bcl-2 protein in B-chronic lymphocytic leukemia cells in vitro. Br. J. Haematol. 1993; 85: 439-45.
22. Panayiotidis P, Ganeshaguru K, Jabbar SAB, Hoffbrand AV, Alpha-interferon (α-IFN) protects B-chronic lymphocytic leukemia cells from apoptotic cell death in vitro. Br. J. Haematol. 1994; 86: 169-73.
23. Jewell AP, Worman CP, Lydyard PM, Yong KL, Giles FJ, Goldstone AH. Interferon-alpha up-regulates bcl-2 expression and protects B-CLL cells from apoptosis in vitro and in vivo. Br. J. Haematol. 1994; 88: 268-74.
24. Chaouchi N, Wallon C, Taieb J et al. Interferon-α-mediated prevention of in vitro apoptosis of chronic lymphocytic leukemia B cells: Role of bcl-2 and c-myc. Clin. Immunol. Immunother. 1994; 73: 197-204.
25. Fluckiger AC, Durand I, Banchereau J. Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells. J. Exp. Med. 1994; 179: 91-9.
26. Jewell AP, Lydyard PM, Worman CP, Giles FJ, Goldstone AH. Growth factors can protect B-chronic lymphocytic leukemia cells against programmed cell death without stimulating proliferation. Leuk. Lymphoma 1995; 18: 159-62.
27. Chaouchi N, Wallon C, Goujard C et al. Interleukin-13 inhibits interleukin-2-induced proliferation and protects leukemia B cells from in vitro apoptosis. Blood 1996; 87: 1022-9.
28. Mainou-Fowler T, Craig VA, Copplestone JA, Hamon MD, Prentice AG. Interleukin-5 (IL-5) increases spontaneous apoptosis of B-cell chronic lymphocytic leukemia cells in vitro independently of bcl-2 expression, and is inhibited by IL-4. Blood 1994; 84: 2297-304.
29. + leukemic B cells via a T cell independent mechanism. Immunol. Cell Biol. 1995; 73: 44-51.
30. Illera VA, Perandones CE, Stunz LL, Mower DA, Ashman RF. Apoptosis of splenic B lymphocytes: regulation by protein kinase C and IL-4. J. Immunol. 1993; 151: 2965-72.
31. Zurawski G, de Vries JE . Interleukin-13, an interleukin-4-like cytokine that acts on monocytes and B-cells, but not on T cells. Immunol. Today. 1994; 15: 19-26.
32. Luo H, Rubio M, Biron G, Delespesse G, Sarfati M. Antiproliferative effect of interleukin-4 in B chronic lymphocytic leukemia. J. Immunother. 1991; 10: 418-25.
33. Aderka D, Maor Y, Novick D et al. Interleukin-6 inhibits the proliferation of B-chronic lymphocytic leukemia cells that is induced by tumor necrosis factor-α or -β. Blood 1993; 81: 2076-84.
34. Reittic JE, Hoffbrand AV. Interleukin-4 (IL-4) inhibits proliferation and spontaneous cytokine release by chronic lymphocytic leukemia cells. Leuk. Res. 1994; 18: 55-60.
35. Morabito F, Callea V, Oliva B et al. α2-interferon in B-cell chronic lymphocytic leukemia: Clinical response, serum cytokine levels, and immunophenotype modulation. Leukemia 1993; 7: 366-71.
36. Heslop HE, Bianchi A, Cordingley FT et al. Effects of interferon-α on autocrine growth factor loops in B lymphoproliferative disorders. J. Exp. Med. 1990; 172: 1729-34.
37. Cordingley FT, Bianchi A, Hoffbrand AV, et al. Tumor necrosis factor as an autocrine tumor growth factor for chronic B-cell malignancies. Lancet 1988; 2: 969-71.
38. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu. Rev. Immunol. 1993; 11: 165-90.
39. Ishida H, Hastings R, Thompson-Snipes L, Howard M. Modified immunological status of anti-IL-10 treated mice. Cell. Immunol. 1993; 148: 371-84.